|
US4782071A
(en)
|
1986-11-03 |
1988-11-01 |
Warner-Lambert Company |
Tetrasubstituted urea cholinergic agents
|
|
CN1128139C
(zh)
|
1995-01-11 |
2003-11-19 |
三进制药株式会社 |
新哌嗪衍生物及其制造方法
|
|
TW360653B
(en)
|
1995-03-01 |
1999-06-11 |
Janssen Pharmaceutica Nv |
A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition
|
|
AU4414999A
(en)
|
1998-06-08 |
1999-12-30 |
Sambasiva R. Chavali |
Inhibition of delta-9-desaturase activity by saponins
|
|
US6107313A
(en)
|
1998-10-02 |
2000-08-22 |
Combichem, Inc. |
Dopamine receptor antagonists
|
|
US20070087363A1
(en)
|
1998-12-22 |
2007-04-19 |
Myriad Genetics, Incorporated |
Therapeutic methods, compounds and compositions
|
|
BR0012046A
(pt)
*
|
1999-07-01 |
2002-05-14 |
Ajinomoto Kk |
Composto heterocìclico, composição farmacêutica, inibidor de ativação de ap-1 ou um inibidor da ativação de nf-kappab, inibidor da produção de citocina inflamatória, e, inibidor da produção de metaloprotease de matriz ou inibidor da expressão do fator de adesão de célula inflamatória
|
|
ES2546386T3
(es)
|
1999-07-20 |
2015-09-23 |
Dow Agrosciences, Llc |
Amidas aromáticas heterocíclicas fungicidas y sus composiciones, métodos de uso y preparación
|
|
PL205059B1
(pl)
|
1999-08-20 |
2010-03-31 |
Dow Agrosciences Llc |
Heterocykliczny amid aromatyczny, jego kompozycja grzybobójcza oraz sposób zwalczania lub zapobiegania zakażeniom grzybami
|
|
WO2001062954A2
(en)
|
2000-02-24 |
2001-08-30 |
Xenon Genetics, Inc. |
Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
|
|
ES2320973T3
(es)
|
2000-06-12 |
2009-06-01 |
EISAI R&D MANAGEMENT CO., LTD. |
Compuestos de 1,2-dihidropiridina, procedimiento para su preparacion y uso de los mismos.
|
|
WO2001095856A2
(en)
|
2000-06-15 |
2001-12-20 |
Chaconne Nsi Co., Ltd. |
Urea derivative useful as an anti-cancer agent and process for preparing same
|
|
AU2002218091A1
(en)
|
2000-11-17 |
2002-05-27 |
Xenon Genetics Inc |
Fat regulated genes, uses thereof, and compounds for modulating same
|
|
US6995162B2
(en)
*
|
2001-01-12 |
2006-02-07 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
|
US20050256068A1
(en)
|
2001-05-18 |
2005-11-17 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of stearoyl-CoA desaturase (SCD) gene expression using short interfering nucleic acid (siNA)
|
|
US20050043256A1
(en)
|
2001-07-30 |
2005-02-24 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of stearoyl-CoA desaturase expression
|
|
US6727247B2
(en)
|
2001-12-10 |
2004-04-27 |
Hoffman-La Roche Inc. |
Substituted benzothiazole amide derivatives
|
|
AU2003215203A1
(en)
|
2002-02-20 |
2003-09-09 |
Sirna Therapeutics, Inc. |
Short interfering nucleic acid inhibition of stearoyl-coa desaturase (scd) gene
|
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
|
US7105505B2
(en)
|
2002-04-18 |
2006-09-12 |
Schering Corporation |
Benzimidazole derivatives useful as histamine H3 antagonists
|
|
US7074809B2
(en)
|
2002-08-09 |
2006-07-11 |
Astrazeneca Ab |
Compounds
|
|
MXPA05001603A
(es)
|
2002-08-13 |
2005-04-25 |
Warner Lambert Co |
Derivados monociclicos como inhibidores de metaloproteinasa de matriz.
|
|
CN100364531C
(zh)
|
2002-12-18 |
2008-01-30 |
西托维亚公司 |
3,5－二取代－[1,2,4]－二唑及类似物和其用途
|
|
BRPI0411275A
(pt)
*
|
2003-06-10 |
2006-08-01 |
Kalypsys Inc |
compostos de carbonila como inibidores de histona deacetilase para tratamento de doenças; composição farmacêutica; método de modular a atividade catalìtica de hdac; método de tratar doença em um indivìduo; utilização de um composto ou composição; método de inibir hdac
|
|
MXPA06001202A
(es)
|
2003-07-29 |
2006-08-31 |
Xenon Pharmaceuticals Inc |
Derivados piridilo y su uso como agentes terapeuticos.
|
|
US7754711B2
(en)
|
2003-07-30 |
2010-07-13 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives and their use as therapeutic agents
|
|
US7456180B2
(en)
|
2003-07-30 |
2008-11-25 |
Xenon Pharmaceuticals Inc. |
Piperazine derivatives and their use as therapeutic agents
|
|
CA2533897A1
(en)
|
2003-07-30 |
2005-02-10 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives and their use as therapeutic agents
|
|
CA2533900A1
(en)
|
2003-07-30 |
2005-02-10 |
Xenon Pharmaceuticals Inc. |
Pyridyl derivatives and their use as therapeutic agents
|
|
PL1648874T3
(pl)
|
2003-07-30 |
2012-04-30 |
Xenon Pharmaceuticals Inc |
Pochodne piperazyny i ich zastosowanie jako środków leczniczych
|
|
US7759348B2
(en)
|
2003-07-30 |
2010-07-20 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives and their use as therapeutic agents
|
|
MXPA06001480A
(es)
*
|
2003-08-06 |
2006-05-15 |
Pfizer Prod Inc |
Compuestos de oxazol para el tratamiento de trastornos neurodegenerativos.
|
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
DE602004008658T2
(de)
|
2003-09-05 |
2008-06-12 |
Cellzome Ag |
Behandlung neurodegenerativer krankheiten
|
|
ZA200602755B
(en)
*
|
2003-09-06 |
2007-06-27 |
Vertex Pharma |
Modulators of ATP-binding cassette transporters
|
|
CA2544502A1
(en)
|
2003-11-25 |
2005-06-09 |
Wisconsin Alumni Research Foundation |
Vitamin d analogs for obesity prevention and treatment
|
|
JP4958560B2
(ja)
|
2003-12-24 |
2012-06-20 |
プロシディオン・リミテッド |
Ｇｐｃｒ受容体作動薬としてのヘテロ環誘導体
|
|
JP2005213233A
(ja)
|
2004-02-02 |
2005-08-11 |
Fuji Oil Co Ltd |
肝臓ステアロイル‐ＣｏＡ不飽和化酵素１合成抑制剤
|
|
US7459562B2
(en)
|
2004-04-23 |
2008-12-02 |
Bristol-Myers Squibb Company |
Monocyclic heterocycles as kinase inhibitors
|
|
US7550651B2
(en)
|
2004-06-25 |
2009-06-23 |
E.I. Du Pont De Nemours And Company |
Delta-8 desaturase and its use in making polyunsaturated fatty acids
|
|
ATE537830T1
(de)
|
2004-07-06 |
2012-01-15 |
Xenon Pharmaceuticals Inc |
Nicotinamid derivate und ihre verwendung als therapeutika
|
|
US8008302B2
(en)
|
2004-07-26 |
2011-08-30 |
Merck Serono Sa |
N-hydroxyamide derivatives and use thereof
|
|
ATE392471T1
(de)
|
2004-08-09 |
2008-05-15 |
Cellzome Ag |
Behandlung neurodegenerativer krankheiten durch verwendung von scd4-inhibitoren
|
|
WO2006022442A1
(ja)
*
|
2004-08-24 |
2006-03-02 |
Santen Pharmaceutical Co., Ltd. |
ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
|
|
MX2007003318A
(es)
|
2004-09-20 |
2007-05-18 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como agentes terapeuticos.
|
|
AU2005286647A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
|
|
AU2005286728A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
|
|
EP1827438B2
(en)
|
2004-09-20 |
2014-12-10 |
Xenon Pharmaceuticals Inc. |
Piperazin derivatives for inhibiting human stearoyl-coa-desaturase
|
|
AU2005286790A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-CoA-desaturase (SCD)
|
|
MX2007003332A
(es)
|
2004-09-20 |
2007-06-05 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
|
|
CN101084211A
(zh)
|
2004-09-20 |
2007-12-05 |
泽农医药公司 |
杂环衍生物及其作为治疗剂的用途
|
|
BRPI0515500A
(pt)
|
2004-09-20 |
2008-07-29 |
Xenon Pharmaceuticals Inc |
derivados piridazina para inibição de estearoil-coa-desaturase
|
|
ES2547724T3
(es)
|
2004-11-10 |
2015-10-08 |
Incyte Corporation |
Compuestos de lactama y su uso como productos farmacéuticos
|
|
CA2588412A1
(en)
|
2004-11-22 |
2006-06-01 |
Wisconsin Alumni Research Foundation |
2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses
|
|
GT200500375A
(es)
|
2004-12-20 |
2006-11-28 |
|
Derivados de piperidina y su uso como agentes antiinflamatorios
|
|
NZ556017A
(en)
|
2004-12-24 |
2009-10-30 |
Prosidion Ltd |
G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes
|
|
JP2008525478A
(ja)
|
2004-12-27 |
2008-07-17 |
アストラゼネカ アクチボラグ |
神経系及び精神医学系障害の治療のための代謝共役型グルタミン酸受容体アゴニストとしてのピラゾロン化合物
|
|
NZ590148A
(en)
|
2004-12-30 |
2012-04-27 |
Janssen Pharmaceutica Nv |
Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
|
|
BRPI0519794A2
(pt)
|
2005-01-07 |
2009-03-17 |
Hoffmann La Roche |
derivados de [4-(heteroaril)piperazin-1-il]-(fenil 2,5-substituìdo)metanona como inibidores de transportador de glicina 1 (glyt-1) para o tratamento de distúrbios neurológicos e neuropsiquiátricos
|
|
GT200600046A
(es)
|
2005-02-09 |
2006-09-25 |
|
Terapia de combinacion
|
|
JO2787B1
(en)
*
|
2005-04-27 |
2014-03-15 |
امجين إنك, |
Alternative amide derivatives and methods of use
|
|
WO2006125181A2
(en)
|
2005-05-19 |
2006-11-23 |
Xenon Pharmaceuticals Inc. |
Piperidine derivatives and their use as stearoyl-coa desaturase modulators
|
|
WO2006125194A2
(en)
|
2005-05-19 |
2006-11-23 |
Xenon Pharmaceuticals Inc. |
Piperazine derivatives and their uses as therapeutic agents
|
|
WO2006125179A1
(en)
|
2005-05-19 |
2006-11-23 |
Xenon Pharmaceuticals Inc. |
Tricyclic compounds and their uses as therapeutic agents
|
|
WO2007044085A2
(en)
|
2005-05-19 |
2007-04-19 |
Xenon Pharmaceuticals Inc. |
Heteroaryl compounds and their uses as therapeutic agents
|
|
WO2007046868A2
(en)
|
2005-05-19 |
2007-04-26 |
Xenon Pharmaceuticals Inc. |
Thiazolidine derivatives and their uses as therapeutic agents
|
|
CA2618646A1
(en)
*
|
2005-06-03 |
2007-11-15 |
Xenon Pharmaceuticals Inc. |
Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
|
|
CA2610196A1
(en)
|
2005-06-09 |
2006-12-14 |
Merck Frosst Canada Ltd. |
Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
US20090118296A1
(en)
|
2005-07-20 |
2009-05-07 |
Merck Frosst Canada Ltd. |
Heteroaromatic Compounds As Inhibitors Of Stearoyl-Coenzyme A Delta-9 Desaturase
|
|
AU2006315025A1
(en)
|
2005-11-15 |
2007-05-24 |
Merck Frosst Canada Ltd. |
Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2007076055A2
(en)
|
2005-12-22 |
2007-07-05 |
Entremed, Inc. |
Compositions and methods comprising proteinase activated receptor antagonists
|
|
MX2008008529A
(es)
|
2005-12-29 |
2008-09-26 |
Organon Nv |
Inhibidores de amida hidrolasa de acido graso.
|
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
|
WO2007136746A2
(en)
|
2006-05-19 |
2007-11-29 |
Xenon Pharmaceuticals Inc. |
Macrocyclic compounds and their uses as stearoyl-coa desaturase
|
|
JP2009537571A
(ja)
|
2006-05-22 |
2009-10-29 |
メルク フロスト カナダ リミテツド |
ステアロイル−コエンザイムａデルタ−９デサチュラーゼのインヒビターとしての環状アミン誘導体
|
|
WO2007143597A2
(en)
|
2006-06-05 |
2007-12-13 |
Novartis Ag |
Organic compounds
|
|
JP2009539884A
(ja)
|
2006-06-12 |
2009-11-19 |
メルク フロスト カナダ リミテツド |
ステアロイル−コエンザイムａデルタ−９デサチュラーゼのインヒビターとしてのアゼチジン誘導体
|
|
CA2654098A1
(en)
|
2006-06-13 |
2007-12-21 |
Merck Frosst Canada Ltd. |
Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
WO2008003753A1
(en)
|
2006-07-07 |
2008-01-10 |
Biovitrum Ab (Publ) |
Pyrazolo [1,5-a] pyrimidine analogs for use as inhibitors of stearoyl-coa desaturase (scd) activity
|
|
WO2008008852A2
(en)
|
2006-07-11 |
2008-01-17 |
Emory University |
Cxcr4 antagonists including heteroatoms for the treatment of medical disorders
|
|
US8080659B2
(en)
|
2006-07-11 |
2011-12-20 |
Emory University |
CXCR4 antagonists including diazine and triazine structures for the treatment of medical disorders
|
|
WO2008008059A1
(en)
|
2006-07-12 |
2008-01-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents ans uses thereof
|
|
CA2660114A1
(en)
|
2006-08-09 |
2008-02-14 |
Merck Frosst Canada Ltd. |
Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
MX2009001634A
(es)
|
2006-08-15 |
2009-02-25 |
Novartis Ag |
Compuestos heterociclicos adecuados para el tratamiento de enfermedades relacionadas con el nivel elevado de lipidos.
|
|
WO2008024139A2
(en)
|
2006-08-18 |
2008-02-28 |
N.V. Organon |
Inhibitors of fatty acid amide hydrolase
|
|
US20110172230A1
(en)
|
2006-08-23 |
2011-07-14 |
Takahiro Ishii |
Urea compound or salt thereof
|
|
MX2009002019A
(es)
|
2006-08-24 |
2009-03-09 |
Novartis Ag |
Derivados de 2-(pirazin-2-il)-tiazol y 2-(1h-pirazol-3-il)-tiazol asi como compuestos relacionados como inhibidores de la estearoil-coa-desaturasa (scd) para el tratamiento de trastornos metabolicos, cardiovasculares, y otros.
|
|
WO2008029266A1
(en)
|
2006-09-08 |
2008-03-13 |
Glenmark Pharmaceuticals S.A. |
Stearoyl coa desaturase inhibitors
|
|
CA2662574A1
(en)
|
2006-09-22 |
2008-03-27 |
Novartis Ag |
Heterocyclic organic compounds
|
|
CA2665476A1
(en)
|
2006-10-05 |
2008-04-10 |
Cv Therapeutics, Inc. |
Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors
|
|
US7893066B2
(en)
|
2006-10-05 |
2011-02-22 |
Gilead Palo Alto, Inc. |
Pyridol[2,3-B]pyrazinones for use as stearoyl CoA desaturase inhibitors
|
|
WO2008044767A1
(en)
*
|
2006-10-13 |
2008-04-17 |
Takeda Pharmaceutical Company Limited |
Aromatic amine derivative and use thereof
|
|
CA2664849A1
(en)
|
2006-10-20 |
2008-04-24 |
Merck Frosst Canada Ltd. |
Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2008057280A1
(en)
|
2006-10-27 |
2008-05-15 |
Amgen Inc. |
Multi-cyclic compounds and methods of use
|
|
WO2008056687A1
(en)
|
2006-11-09 |
2008-05-15 |
Daiichi Sankyo Company, Limited |
Novel spiropiperidine derivative
|
|
WO2008062276A2
(en)
|
2006-11-20 |
2008-05-29 |
Glenmark Pharmaceuticals S.A. |
Acetylene derivatives as stearoyl coa desaturase inhibitors
|
|
KR101450356B1
(ko)
|
2006-11-24 |
2014-10-15 |
에이씨 이뮨 에스.에이. |
알츠하이머와 같은 아밀로이드 또는 아밀로이드-유사 단백질과 관련된 질환의 치료를 위한 ｎ-(메틸)-1ｈ-피라졸-3-아민, ｎ-(메틸)-피리딘-2-아민 및 ｎ-(메틸)-티아졸-2-아민 유도체
|
|
TW200826936A
(en)
|
2006-12-01 |
2008-07-01 |
Merck Frosst Canada Ltd |
Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
CN101589039B
(zh)
|
2006-12-01 |
2012-09-05 |
默克弗罗斯特加拿大有限公司 |
作为硬脂酰辅酶a △-9去饱和酶抑制剂的氮杂环烷衍生物
|
|
EP2109364A4
(en)
|
2006-12-15 |
2010-04-14 |
Abbott Lab |
NOVEL OXADIAZONE COMPOUNDS
|
|
WO2008074835A1
(en)
|
2006-12-20 |
2008-06-26 |
Novartis Ag |
2-substituted 5-membered heterocycles as scd inhibitors
|
|
GB0625594D0
(en)
|
2006-12-21 |
2007-01-31 |
Smithkline Beecham Corp |
Compounds
|
|
GB0625604D0
(en)
|
2006-12-21 |
2007-01-31 |
Smithkline Beecham Corp |
Compounds
|
|
GB0625654D0
(en)
|
2006-12-21 |
2007-01-31 |
Smithkline Beecham Corp |
Compounds
|
|
GB0625605D0
(en)
|
2006-12-21 |
2007-01-31 |
Smithkline Beecham Corp |
Compounds
|
|
EP2518063B1
(en)
|
2006-12-21 |
2017-02-01 |
Sloan-Kettering Institute For Cancer Research |
Pyridazinones and furan-containing compounds
|
|
AR064965A1
(es)
|
2007-01-26 |
2009-05-06 |
Merck Frosst Canada Inc |
Derivados de azacicloalcanos como inhibidores de estearoil - coenzima a delta -9 desaturasa
|
|
US8575167B2
(en)
|
2007-02-06 |
2013-11-05 |
Takeda Pharmaceutical Company Limited |
Spiro compounds having stearoyl-CoA desaturase action
|
|
EP2125799A1
(en)
|
2007-02-28 |
2009-12-02 |
Smithkline Beecham Corporation |
Thiadiazole derivatives, inhibitors of stearoyl-coa desaturase
|
|
CA2682016A1
(en)
|
2007-03-28 |
2008-10-02 |
Inovacia Ab |
Pyrazolo [1,5-a]pyrimidines as inhibitors of stearoyl-coa desaturase
|
|
WO2008120744A1
(ja)
|
2007-03-30 |
2008-10-09 |
Japan Tobacco Inc. |
５員環アミド化合物およびその用途
|
|
WO2008123469A1
(ja)
*
|
2007-03-30 |
2008-10-16 |
Japan Tobacco Inc. |
６員環アミド化合物およびその用途
|
|
WO2008120759A1
(ja)
|
2007-03-30 |
2008-10-09 |
Japan Tobacco Inc. |
ウレア化合物およびその用途
|
|
CA2681560A1
(en)
|
2007-04-09 |
2008-10-16 |
Cv Therapeutics, Inc. |
Pteridinone derivatives for use as stearoyl coa desaturase inhibitors
|
|
US20080255161A1
(en)
|
2007-04-11 |
2008-10-16 |
Dmitry Koltun |
3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
|
|
WO2008128335A1
(en)
|
2007-04-20 |
2008-10-30 |
Merck Frosst Canada Ltd. |
Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2008139845A1
(ja)
|
2007-04-24 |
2008-11-20 |
Daiichi Sankyo Company, Limited |
新規アミド誘導体
|
|
CA2687338A1
(en)
|
2007-05-23 |
2008-11-27 |
Merck Frosst Canada Ltd. |
Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2008157844A1
(en)
|
2007-06-21 |
2008-12-24 |
Forest Laboratories Holdings Limited |
Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase
|
|
JP2009019013A
(ja)
|
2007-07-12 |
2009-01-29 |
Daiichi Sankyo Co Ltd |
新規ヘテロアリールピペリジン誘導体
|
|
GB0714129D0
(en)
|
2007-07-19 |
2007-08-29 |
Smithkline Beecham Corp |
compounds
|
|
CA2693290A1
(en)
|
2007-07-20 |
2009-01-29 |
Merck Frosst Canada Ltd. |
Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
GB0715055D0
(en)
|
2007-08-02 |
2007-09-12 |
Smithkline Beecham Corp |
Compounds
|
|
BRPI0815048B8
(pt)
|
2007-08-08 |
2021-05-25 |
Graceway Pharmaceuticals Llc |
derivados de fenóxi-pirrolidinas, seus usos e composições farmacêuticas
|
|
WO2009021990A1
(en)
|
2007-08-14 |
2009-02-19 |
Bayer Schering Pharma Aktiengesellschaft |
Fused imidazoles for cancer treatment
|
|
BRPI0817211A2
(pt)
|
2007-09-20 |
2017-05-16 |
Irm Llc |
composto composições como moduladores da atividade de gpr119
|
|
WO2009037542A2
(en)
|
2007-09-20 |
2009-03-26 |
Glenmark Pharmaceuticals, S.A. |
Spirocyclic compounds as stearoyl coa desaturase inhibitors
|
|
GB0721419D0
(en)
*
|
2007-10-31 |
2007-12-12 |
Smithkline Beecham Corp |
Compounds
|
|
GB0722075D0
(en)
|
2007-11-09 |
2007-12-19 |
Smithkline Beecham Corp |
Compounds
|
|
GB0722077D0
(en)
|
2007-11-09 |
2007-12-19 |
Smithkline Beecham Corp |
Compounds
|
|
WO2009070533A1
(en)
|
2007-11-29 |
2009-06-04 |
Complegen, Inc. |
Methods of inhibiting steroyl coa desaturase
|
|
WO2009073973A1
(en)
|
2007-12-11 |
2009-06-18 |
Merck Frosst Canada Ltd. |
Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2009074487A1
(en)
|
2007-12-11 |
2009-06-18 |
F. Hoffmann-La Roche Ag |
Inhibitors of stearoyl-coa desaturase
|
|
WO2009086303A2
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
ATE552239T1
(de)
|
2007-12-28 |
2012-04-15 |
Wisconsin Alumni Res Found |
2-methylen-20-methyl-19,24,25,26,27-pentanor- vitamin-d-analoga
|
|
WO2009103739A1
(en)
|
2008-02-20 |
2009-08-27 |
Novartis Ag |
Heterocyclic inhibitors of stearoyl-coa desaturase
|
|
NZ720282A
(en)
*
|
2008-02-28 |
2017-12-22 |
Vertex Pharma |
Heteroaryl derivatives as cftr modulators
|
|
EP2307023A4
(en)
|
2008-03-20 |
2011-07-20 |
Forest Lab Holdings Ltd |
NEW PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL COA DESATURASE
|
|
RU2010142937A
(ru)
|
2008-03-20 |
2012-04-27 |
Форест Лабораториес Холдингс Лимитед (Bm) |
НОВЫЕ ПРОИЗВОДНЫЕ ПИПЕРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ СТЕАРОИЛ-КоА ДЕСАТУРАЗЫ
|
|
EP2271621B1
(en)
*
|
2008-03-31 |
2013-11-20 |
Vertex Pharmaceuticals Incorporated |
Pyridyl derivatives as cftr modulators
|
|
WO2009124259A1
(en)
|
2008-04-04 |
2009-10-08 |
Cv Therapeutics, Inc. |
Pyrrolotriazinone derivatives for use as stearoyl coa desaturase inhibitors
|
|
BRPI0910987A2
(pt)
|
2008-04-04 |
2017-03-21 |
Gilead Sciences Inc |
derivados de triazolopiridinona para uso como inibidores de estearoil-coa dessaturase
|
|
JP2011516494A
(ja)
|
2008-04-07 |
2011-05-26 |
ギリアード サイエンシーズ， インコーポレイテッド |
ステアロイル−ＣｏＡデサチュラーゼの阻害剤として使用するための２Ｈ−ベンゾ［ｂ］［１，４］オキサジン−３（４Ｈ）−オン誘導体
|
|
WO2009129625A1
(en)
|
2008-04-22 |
2009-10-29 |
Merck Frosst Canada Ltd. |
Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
GB0810913D0
(en)
*
|
2008-06-13 |
2008-07-23 |
Smithkline Beecham Corp |
Comppounds
|
|
US8822513B2
(en)
|
2010-03-01 |
2014-09-02 |
Gtx, Inc. |
Compounds for treatment of cancer
|
|
US9447049B2
(en)
|
2010-03-01 |
2016-09-20 |
University Of Tennessee Research Foundation |
Compounds for treatment of cancer
|
|
US9187426B2
(en)
|
2008-06-27 |
2015-11-17 |
Novartis Ag |
Organic compounds
|
|
TWI434842B
(zh)
|
2008-07-14 |
2014-04-21 |
Astellas Pharma Inc |
Azole compounds
|
|
FR2933979B1
(fr)
|
2008-07-15 |
2012-08-24 |
Pf Medicament |
Derives de triazines et uraciles, leur preparation et leur application en therapeutique humaine
|
|
WO2010007482A2
(en)
|
2008-07-16 |
2010-01-21 |
Glenmark Pharmaceuticals S.A. |
Thiazole derivatives as stearoyl coa desaturase inhibitors
|
|
GB0813740D0
(en)
|
2008-07-28 |
2008-09-03 |
Angeletti P Ist Richerche Biologica |
Therapeutic compounds
|
|
JP2010043052A
(ja)
|
2008-08-18 |
2010-02-25 |
Mitsubishi Chemicals Corp |
カロテノイド類の分離方法
|
|
WO2010022055A2
(en)
|
2008-08-20 |
2010-02-25 |
Amgen Inc. |
Inhibitors of voltage-gated sodium channels
|
|
WO2010025553A1
(en)
|
2008-09-08 |
2010-03-11 |
Merck Frosst Canada Ltd. |
Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
US8673917B2
(en)
|
2008-09-09 |
2014-03-18 |
Sanofi |
2-heteroaryl-pyrrolo [3,4-C]pyrrole derivatives, and use thereof as SCD inhibitors
|
|
WO2010039186A2
(en)
|
2008-09-23 |
2010-04-08 |
Renovis, Inc. |
Compounds useful as faah modulators and uses thereof
|
|
US20110184027A1
(en)
|
2008-09-25 |
2011-07-28 |
Glenmark Pharmaceuticals S.A. |
Tissue selective stearoyl-coa desaturase 1 inhibitors and cell based screening assay for their identification
|
|
EP2350097A1
(en)
|
2008-10-02 |
2011-08-03 |
Merck Frosst Canada Ltd. |
Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2010056230A1
(en)
|
2008-10-15 |
2010-05-20 |
Cv Therapeutics, Inc. |
3-hydroquinazolin-4-one derivatives for use as stearoyl coa desaturase inhibitors
|
|
US20100267752A1
(en)
|
2008-10-15 |
2010-10-21 |
Gilead Palo Alto, Inc. |
3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
|
|
US20100267748A1
(en)
|
2008-10-15 |
2010-10-21 |
Gilead Palo Alto, Inc. |
HETEROCYCLIC COMPOUNDS USEFUL AS STEAROYL CoA DESATURASE INHIBITORS
|
|
US20110183958A1
(en)
|
2008-10-17 |
2011-07-28 |
Merck Frosst Canada Ltd. |
Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
|
GB0821307D0
(en)
|
2008-11-21 |
2008-12-31 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
|
EP2192196A1
(en)
|
2008-11-27 |
2010-06-02 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Prediction of lipid-metabotype-related physiological susceptibilities
|
|
US20100160323A1
(en)
|
2008-12-23 |
2010-06-24 |
Alexander Bischoff |
NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE
|
|
EP2398809B1
(en)
|
2009-02-17 |
2015-07-08 |
Merck Canada Inc. |
Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
US20110301143A1
(en)
|
2009-02-23 |
2011-12-08 |
Elise Isabel |
Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
US8901306B2
(en)
|
2009-03-02 |
2014-12-02 |
Stemsynergy Therapeutics, Inc. |
Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell
|
|
US20120010186A1
(en)
|
2009-03-23 |
2012-01-12 |
Merck Frosst Canada Ltd. |
Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
CN102388052A
(zh)
|
2009-04-01 |
2012-03-21 |
诺瓦提斯公司 |
调节硬脂酰基-CoA去饱和酶的螺环衍生物
|
|
CA2768577A1
(en)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
|
|
WO2011011506A1
(en)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
|
|
EP2459568A4
(en)
|
2009-07-28 |
2013-02-27 |
Merck Frosst Canada Ltd |
NEW SPIRO COMPOUNDS AS AN INHIBITORS OF STEAROYL COENZYME A DELTA 9 DESATURASE
|
|
FR2948939B1
(fr)
|
2009-08-05 |
2013-03-22 |
Pf Medicament |
Derives de 2h pyridazin-3-ones, leur preparation et leur application en therapeutique humaine
|
|
US8354403B2
(en)
|
2009-08-27 |
2013-01-15 |
Merck Sharp & Dohme Corp. |
Pyrrolidine derived beta 3 adrenergic receptor agonists
|
|
WO2011028689A1
(en)
|
2009-09-01 |
2011-03-10 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid niacin conjugates and their uses
|
|
EP2475367A1
(en)
|
2009-09-10 |
2012-07-18 |
Centre National De La Recherche Scientifique |
NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES
|
|
BR112012007509A2
(pt)
*
|
2009-10-01 |
2016-11-22 |
Novartis Ag |
derivados pirazóis que modulam estearoil-coa dessaturase
|
|
WO2011047481A1
(en)
|
2009-10-23 |
2011-04-28 |
Merck Frosst Canada Ltd. |
Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
PL2516425T3
(pl)
|
2009-12-23 |
2016-03-31 |
Jasco Pharmaceuticals Llc |
Inhibitory kinaz aminopirydynowych
|
|
JP5879273B2
(ja)
|
2010-03-01 |
2016-03-08 |
ジーティーエックス・インコーポレイテッド |
癌を処置するための化合物
|
|
WO2011123681A1
(en)
|
2010-03-31 |
2011-10-06 |
Rigel Pharmaceuticals, Inc. |
Methods for using carboxamide, sulfonamide and amine compounds
|
|
FR2958935B1
(fr)
|
2010-04-19 |
2012-06-22 |
Pf Medicament |
Derives d'heterocycles azotes, leur preparation et leur application en therapeutique humaine
|
|
WO2011157793A1
(en)
|
2010-06-17 |
2011-12-22 |
Novartis Ag |
Piperidinyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives
|
|
US20130259830A1
(en)
|
2010-07-12 |
2013-10-03 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
|
PE20130774A1
(es)
|
2010-07-29 |
2013-06-26 |
Rigel Pharmaceuticals Inc |
Compuestos heterociclicos activadores de ampk y metodos para emplearlos
|
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
|
PT2616465E
(pt)
|
2010-09-13 |
2016-03-09 |
Novartis Ag |
Triazino-oxadiazoles
|
|
EP2626351A4
(en)
|
2010-10-04 |
2014-03-12 |
Kowa Co |
MEANS FOR INHIBITING THE EXPRESSION OF MRNA INVOLVED IN THE FAT REPLACEMENT
|
|
GB201114389D0
(en)
|
2011-08-22 |
2011-10-05 |
Prosidion Ltd |
Novel compounds
|
|
WO2012066077A1
(en)
|
2010-11-18 |
2012-05-24 |
Prosidion Limited |
1,4 di substituted pyrrolidine - 3 - yl -amine derivatives and their use for the treatment of metabolic disorders
|
|
EP2455080A1
(en)
|
2010-11-23 |
2012-05-23 |
Almirall, S.A. |
S1P1 receptor agonists for use in the treatment of multiple sclerosis
|
|
EP2455081A1
(en)
|
2010-11-23 |
2012-05-23 |
Almirall, S.A. |
S1P1 receptor agonists for use in the treatment of crohn's disease
|
|
GB201021103D0
(en)
|
2010-12-13 |
2011-01-26 |
Univ Leuven Kath |
New compounds for the treatment of neurodegenerative diseases
|
|
WO2012080729A2
(en)
|
2010-12-14 |
2012-06-21 |
Electrophoretics Limited |
CASEIN KINASE 1δ (CK1δ) INHIBITORS
|
|
JP6097998B2
(ja)
*
|
2010-12-16 |
2017-03-22 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ロイコトリエン生成のビアリールアミドインヒビター
|
|
CN103328482A
(zh)
|
2011-01-03 |
2013-09-25 |
韩美药品株式会社 |
用于调节g蛋白-偶联受体的新双环化合物
|
|
JP5935154B2
(ja)
|
2011-03-14 |
2016-06-15 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｇｐｒ１１９モジュレーターとしてのｎ−シクロプロピル−ｎ−ピペリジニルベンズアミド
|
|
EP2694482A1
(en)
|
2011-04-04 |
2014-02-12 |
Siena Biotech S.p.A. |
Wnt pathway antagonists
|
|
CN103748087A
(zh)
|
2011-06-07 |
2014-04-23 |
大日本住友制药株式会社 |
吲唑和吡咯并吡啶衍生物和其药学用途
|
|
US20120316182A1
(en)
*
|
2011-06-10 |
2012-12-13 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
AU2012280420B2
(en)
|
2011-07-01 |
2017-01-05 |
Remynd Nv |
1, 2, 4 -thiadiazol- 5 -ylpiperazine derivatives useful in the treatment neurodegenerative diseases
|
|
JP2014525450A
(ja)
|
2011-09-01 |
2014-09-29 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
ｃ−Ｋｉｔキナーゼ阻害剤としての化合物および組成物
|
|
BR112014007310A2
(pt)
|
2011-09-27 |
2017-04-04 |
Novartis Ag |
3-pirimidin-4-il-oxazolidin-2-onas como inibidores de idh mutante
|
|
US9358250B2
(en)
|
2011-10-15 |
2016-06-07 |
Genentech, Inc. |
Methods of using SCD1 antagonists
|
|
DK2776387T3
(en)
|
2011-11-07 |
2017-05-08 |
Univ Emory |
Tricyclic amino containing compounds to treat or prevent symptoms associated with endocrine dysfunction
|
|
WO2013085957A1
(en)
|
2011-12-06 |
2013-06-13 |
Janssen Pharmaceutica Nv |
Substituted piperidinyl-pyridazinyl derivatives useful as scd 1 inhibitors
|
|
WO2013085954A1
(en)
|
2011-12-06 |
2013-06-13 |
Janssen Pharmaceutica Nv |
Substituted piperidinyl-carboxamide derivatives useful as scd 1 inhibitors
|
|
US8530461B2
(en)
|
2011-12-29 |
2013-09-10 |
Boehringer Ingelheim International Gmbh |
Azetidine derivatives
|
|
WO2013130625A1
(en)
|
2012-02-27 |
2013-09-06 |
Basil Rigas |
Phospho-ester derivatives and uses thereof
|
|
US9233102B2
(en)
|
2012-03-07 |
2016-01-12 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
EP2841080A4
(en)
|
2012-04-23 |
2015-11-25 |
Piramal Entpr Ltd |
COMPOSITION FOR THE TREATMENT OF METABOLISM DISORDERS
|
|
WO2013170072A2
(en)
|
2012-05-09 |
2013-11-14 |
Neurop, Inc. |
Compounds for the treatment of neurological disorders
|
|
MX2014014174A
(es)
|
2012-05-22 |
2015-07-06 |
Hoffmann La Roche |
Inhibidores selectivos de celulas no diferenciadas.
|
|
WO2014003153A1
(ja)
|
2012-06-28 |
2014-01-03 |
協和発酵キリン株式会社 |
置換アミド化合物
|
|
WO2014031928A2
(en)
|
2012-08-24 |
2014-02-27 |
Philip Jones |
Heterocyclic modulators of hif activity for treatment of disease
|
|
EA201500399A1
(ru)
|
2012-10-10 |
2015-09-30 |
Актелион Фармасьютиклз Лтд. |
Антагонисты рецептора орексина, которые представляют собой производные [орто-би-(гетеро)арил]-[2-(мета-би-(гетеро)арил)пирролидин-1-ил]метанона
|
|
WO2014065860A1
(en)
*
|
2012-10-24 |
2014-05-01 |
The General Hospital Corporation |
Functionalized 1,2,4,5-tetrazine compounds for use in bioorthogonal coupling reactions
|
|
KR20150090100A
(ko)
|
2012-12-03 |
2015-08-05 |
에프. 호프만-라 로슈 아게 |
스테아로일-CoA 불포화화효소 1(에스씨디 1)의 억제제로서의 치환된 이속사졸 아마이드 화합물
|
|
US9290465B2
(en)
|
2012-12-03 |
2016-03-22 |
Hoffmann-La Roche Inc. |
Substituted isoxazole amine compounds as inhibitors of SCD1
|
|
JP2016028016A
(ja)
|
2012-12-12 |
2016-02-25 |
大日本住友製薬株式会社 |
オキサジアゾール誘導体とその医薬用途
|
|
US9416102B2
(en)
|
2013-01-23 |
2016-08-16 |
Wisconsin Alumni Research Foundation |
(22E)-2-methylene-22-dehydro-1α,24,25-trihydroxy-19-nor-vitamin D3 analogs
|
|
TWI594975B
(zh)
*
|
2013-04-24 |
2017-08-11 |
第一三共股份有限公司 |
二羧酸化合物
|
|
KR101524650B1
(ko)
|
2013-07-30 |
2015-06-03 |
경상대학교산학협력단 |
테트라하이드로이소퀴놀린 알칼로이드계 화합물 ｙｓ－５１ｓ를 포함하는 대사성 질환의 예방 및 치료용 조성물
|
|
KR20150015305A
(ko)
|
2013-07-31 |
2015-02-10 |
안동대학교 산학협력단 |
주박 추출물을 유효성분으로 함유하는 비만의 예방 또는 치료용 약학적 조성물 및 건강 기능 식품
|
|
US20150087673A1
(en)
|
2013-09-26 |
2015-03-26 |
Rigel Pharmaceuticals, Inc. |
Methods for using and biomarkers for ampk-activating compounds
|
|
EP3055298B1
(en)
*
|
2013-10-11 |
2020-04-29 |
Sutro Biopharma, Inc. |
Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
|
|
CN104163794A
(zh)
|
2013-10-17 |
2014-11-26 |
中国药科大学 |
2-氨基芳环类血管内皮生长因子受体(vegfr)抑制剂及其制备方法和用途
|
|
US9796701B2
(en)
|
2013-12-31 |
2017-10-24 |
Xuanzhu Pharma Co., Ltd. |
Kinase inhibitor and use thereof
|
|
EP3099682A1
(en)
|
2014-01-29 |
2016-12-07 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted isothiazoles
|
|
GB201403969D0
(en)
|
2014-03-06 |
2014-04-23 |
Isis Innovation |
Compounds for use in controlling body fat
|
|
WO2015137385A1
(ja)
|
2014-03-12 |
2015-09-17 |
武田薬品工業株式会社 |
ピリダジン化合物
|
|
WO2015140130A1
(en)
|
2014-03-17 |
2015-09-24 |
Remynd Nv |
Oxadiazole compounds
|
|
WO2016022626A1
(en)
|
2014-08-06 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
Heterocyclic cgrp receptor antagonists
|
|
WO2016022955A1
(en)
|
2014-08-07 |
2016-02-11 |
Mayo Foundation For Medical Education And Research |
Compounds and methods for treating cancer
|
|
KR101715449B1
(ko)
|
2014-08-13 |
2017-03-30 |
주식회사 큐리언트 |
염증성 질환 치료용 화합물
|
|
EP3191578B1
(en)
|
2014-09-12 |
2020-11-04 |
Whitehead Institute for Biomedical Research |
Cells expressing apolipoprotein e and uses thereof
|
|
AU2015319834A1
(en)
|
2014-09-25 |
2017-04-20 |
University Of Notre Dame Du Lac |
Non-beta lactam antibiotics
|
|
EP3034500A1
(en)
|
2014-12-17 |
2016-06-22 |
Genkyotex Sa |
Amido thiazole derivatives as NADPH oxidase inhibitors
|
|
CN105753814A
(zh)
|
2015-01-01 |
2016-07-13 |
成都贝斯凯瑞生物科技有限公司 |
取代氮杂环衍生物及其应用
|
|
US20160223559A1
(en)
*
|
2015-02-02 |
2016-08-04 |
The Regents Of The University Of California |
Tetrazine-containing compounds and synthetic methods thereof
|
|
CN107249583B
(zh)
|
2015-02-09 |
2021-05-07 |
国立大学法人冈山大学 |
乳酸脱氢酶抑制剂以及含有该抑制剂的抗癫痫剂
|
|
CN106146391A
(zh)
|
2015-04-15 |
2016-11-23 |
中国科学院上海药物研究所 |
5-芳香炔基取代的苯甲酰胺类化合物及其制备方法、药物组合物和用途
|
|
WO2017066705A1
(en)
|
2015-10-14 |
2017-04-20 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use against stress granules
|
|
US20200262799A1
(en)
*
|
2015-11-30 |
2020-08-20 |
Universite De Bourgogne |
Process for preparing functionalized 1,2,4,5-tetrazine compounds
|
|
SG11201804901WA
(en)
|
2015-12-22 |
2018-07-30 |
SHY Therapeutics LLC |
Compounds for the treatment of cancer and inflammatory disease
|
|
CA3026982A1
(en)
|
2016-06-08 |
2017-12-14 |
Glaxosmithkline Intellectual Property Development Limited |
Chemical compounds as atf4 pathway inhibitors
|
|
CN109689056A
(zh)
|
2016-08-01 |
2019-04-26 |
亚尼塔公司 |
用于治疗癌症的组合
|
|
JP2019533022A
(ja)
|
2016-10-24 |
2019-11-14 |
ユマニティ セラピューティクス，インコーポレーテッド |
化合物及びその使用
|
|
US11135207B2
(en)
|
2016-12-13 |
2021-10-05 |
Centaurus Therapeutics |
Inhibitors of dihydroceramide desaturase for treating disease
|
|
EP3566055B1
(en)
|
2017-01-06 |
2025-03-12 |
Janssen Pharmaceutica NV |
Scd inhibitor for the treatment of neurological disorders
|
|
EP4606431A3
(en)
|
2017-02-28 |
2025-11-19 |
Mayo Foundation for Medical Education and Research |
Compounds and methods for treating cancer
|
|
WO2018161033A1
(en)
|
2017-03-02 |
2018-09-07 |
Wright, Adrian |
Small molecule ire1-alpha inhibitors
|
|
EP3381908A1
(en)
|
2017-03-27 |
2018-10-03 |
Leadiant Biosciences SA |
2-(4-(4-(bromo-methoxybenzamido)benzylamino)phenyl)benzazole derivatives and their use as anti-heparanase
|
|
CN110621316B
(zh)
|
2017-04-21 |
2024-01-26 |
Epizyme股份有限公司 |
用ehmt2抑制剂进行的组合疗法
|
|
WO2019018795A1
(en)
|
2017-07-20 |
2019-01-24 |
Yumanity Therapeutics |
COMPOUNDS AND USES THEREOF
|
|
CA3083000A1
(en)
|
2017-10-24 |
2019-05-02 |
Yumanity Therapeutics, Inc. |
Compounds and uses thereof
|
|
SG11202004971YA
(en)
|
2017-12-21 |
2020-06-29 |
Gliapharm Sa |
Compositions and methods of treatment for neurological disorders comprising motor neuron diseases
|
|
US20200339591A1
(en)
|
2017-12-21 |
2020-10-29 |
Gliapharm Sa |
Compositions and methods of treatment for neurological disorders comprising a dementia
|
|
JP7346425B2
(ja)
|
2018-01-11 |
2023-09-19 |
セントラス セラピューティクス |
疾患を治療するためのジヒドロセラミドデサチュラーゼ阻害剤
|
|
EP3762034B1
(en)
|
2018-03-05 |
2025-08-27 |
Wylder Nation Foundation |
A fatty acid amide hydrolase (faahi) inhibitor for use in inhibiting the cellular accumulation of a sphingolipid in a subject that has lysosomal storage disease or disorder
|
|
WO2019183587A1
(en)
|
2018-03-23 |
2019-09-26 |
Yumanity Therapeutics, Inc. |
Compounds and uses thereof
|
|
US11243207B2
(en)
|
2018-03-29 |
2022-02-08 |
Mayo Foundation For Medical Education And Research |
Assessing and treating cancer
|
|
WO2019209948A1
(en)
|
2018-04-25 |
2019-10-31 |
Yumanity Therapeutics, Inc. |
Compounds and uses thereof
|
|
JP2021522253A
(ja)
|
2018-04-25 |
2021-08-30 |
ユマニティ セラピューティクス，インコーポレーテッド |
化合物及びその使用
|
|
MA53377A
(fr)
|
2018-07-24 |
2021-06-02 |
Epizyme Inc |
Composés de pyridin-2-one utiles en tant qu'antagonistes de smarca2
|
|
WO2020132378A2
(en)
|
2018-12-22 |
2020-06-25 |
Gliapharm Sa |
Compositions and methods of treatment for neurological disorders comprising depression
|
|
WO2020154571A1
(en)
|
2019-01-24 |
2020-07-30 |
Yumanity Therapeutics, Inc. |
Compounds and uses thereof
|
|
WO2020198026A1
(en)
|
2019-03-22 |
2020-10-01 |
Yumanity Therapeutics, Inc. |
Compounds and uses thereof
|
|
WO2021092240A1
(en)
|
2019-11-05 |
2021-05-14 |
Dermira, Inc. |
Mrgprx2 antagonists for the treatment of inflammatory disorders
|
|
CN114901280B
(zh)
|
2019-11-05 |
2025-05-27 |
德米拉公司 |
MrgprX2拮抗剂及其用途
|
|
EA202192047A1
(ru)
|
2019-11-13 |
2021-12-08 |
Юманити Терапьютикс, Инк. |
Соединения и их применение
|
|
TW202136238A
(zh)
|
2020-01-06 |
2021-10-01 |
大陸商廣東東陽光藥業有限公司 |
RORγt抑制劑及其製備方法和用途
|
|
WO2021154571A1
(en)
|
2020-01-31 |
2021-08-05 |
American Sterilizer Company |
Surgical light head with beam spreading and adjustable power balancing
|